Operating Lease, Right-of-Use Asset in USD of Nuo Therapeutics, Inc. from Q4 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Nuo Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2021 to Q3 2025.
  • Nuo Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $117,962, a 37.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Nuo Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $117,962 -$69,843 -37% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $136,035 -$68,261 -33% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $153,689 -$66,740 -30% 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 $170,940 -$98,414 -37% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 $187,805 -$104,779 -36% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $204,296 -$111,011 -35% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $220,429 -$117,108 -35% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $269,354 -$89,930 -25% 31 Dec 2023 10-K 01 Apr 2025 2024 FY
Q3 2023 $292,584 -$87,981 -23% 30 Sep 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 $315,307 -$86,395 -22% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $337,537 +$253,514 +302% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $359,284 +$359,284 31 Dec 2022 10-K 19 Apr 2024 2023 FY
Q3 2022 $380,565 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 $401,702 30 Jun 2022 10-Q/A 10 Aug 2022 2022 Q2
Q1 2022 $84,023 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $0 31 Dec 2021 10-K 17 Apr 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.